Skip to content
★ Sign in to follow
KV

Kenneth Van Ness

CEO
CytoDyn Inc.
Total declarations
23
Company
1
▲ Purchases (1 ops.)
€449k
▼ Sales (21 ops.)
€83k

Latest filing published 30 Apr 2012 for CytoDyn Inc., €2,222.

Insider track record

Disclosed buys
1
Disclosed sells
21
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kenneth Van Ness: trading record in brief

Kenneth Van Ness discloses dealings in CytoDyn Inc. to SEC (Form 4). Over a trading history stretching from 22 May 2009 to 26 April 2012, the count stands at 23 filings.

Both buying and selling appear: 1 purchase worth €449k, against 21 sales worth €83k. Netting one side against the other leaves €366k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2012: no purchases and 1 sale on the market.

The newest entry dates from 30 April 2012: an open-market sale of €2,222, in CytoDyn Inc. The last purchase on record was published on 2 November 2011, which is 5,486 days ago. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kenneth Van Ness

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations23 total
  • ▼
    President & CEOExecutivesCytoDyn Inc.
    2,932 USD0SEC
    1,396 shares@ US$2.10Common StockSEC:0001200876-12-000044:0
  • ●
    CEO & PresidentExecutivesCytoDyn Inc.
    0SEC
    728,000 shares0Common StockSEC:0001200876-12-000043:0
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    2,000 USD0SEC
    2,500 shares@ US$0.80Common StockSEC:0001200876-11-000057:0
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    593 USD0SEC
    1,041 shares@ US$0.57Common StockSEC:0001200876-11-000057:1
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    5,696 USD0SEC
    8,900 shares@ US$0.64Common StockSEC:0001200876-11-000057:2
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    1,474 USD0SEC
    2,200 shares@ US$0.67Common StockSEC:0001200876-11-000057:3
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    5,004 USD0SEC
    6,950 shares@ US$0.72Common StockSEC:0001200876-11-000057:4
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    19,570 USD0SEC
    24,160 shares@ US$0.81Common StockSEC:0001200876-11-000057:5
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    6,422 USD0SEC
    6,690 shares@ US$0.96Common StockSEC:0001200876-11-000057:6
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    2,425 USD0SEC
    2,500 shares@ US$0.97Common StockSEC:0001200876-11-000057:7
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    19,319 USD0SEC
    18,940 shares@ US$1.02Common StockSEC:0001200876-11-000057:8
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    1,878 USD0SEC
    1,739 shares@ US$1.08Common StockSEC:0001200876-11-000057:9
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    3,086 USD0SEC
    2,805 shares@ US$1.10Common StockSEC:0001200876-11-000057:10
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    7,385 USD0SEC
    6,535 shares@ US$1.13Common StockSEC:0001200876-11-000057:11
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    9,240 USD0SEC
    7,000 shares@ US$1.32Common StockSEC:0001200876-11-000057:12
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    830 USD0SEC
    500 shares@ US$1.66Common StockSEC:0001200876-11-000057:13
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    4,321 USD0SEC
    2,557 shares@ US$1.69Common StockSEC:0001200876-11-000057:14
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    8,750 USD0SEC
    5,000 shares@ US$1.75Common StockSEC:0001200876-11-000057:15
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    2,492 USD0SEC
    1,400 shares@ US$1.78Common StockSEC:0001200876-11-000057:16
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    7,636 USD0SEC
    4,242 shares@ US$1.80Common StockSEC:0001200876-11-000057:17
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    9,750 USD0SEC
    5,000 shares@ US$1.95Common StockSEC:0001200876-11-000057:18
  • ▼
    CEO & PresidentExecutivesCytoDyn Inc.
    579 USD0SEC
    300 shares@ US$1.93Common StockSEC:0001200876-11-000057:19
  • ▲
    CEO & PresidentExecutivesCytoDyn Inc.
    655,200 USD0SEC
    728,000 shares@ US$0.90Common StockSEC:0001200876-11-000057:20
    Canonical exit: 30 Dec 2009 (T+90)

23 of 23 declarations